Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors
Clinical trial NCT07348042 · RECRUITING
Trial details
- NCT number
- NCT07348042
- Sponsor
- Xian-Jun Yu
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-07
- Primary completion
- 2027-03-31
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.